Angioplasty Versus Coronary Artery Bypass in Octogenarians

Size: px
Start display at page:

Download "Angioplasty Versus Coronary Artery Bypass in Octogenarians"

Transcription

1 Angioplasty Versus Coronary Artery Bypass in Octogenarians Tej K. Kaul, FRCS, Barry L. Fields, MD, David A. Wyatt, MD, Christopher R. Jones, MD, and Donald R. Kahn, MD Department of Cardiac Surgery, Princeton-Baptist Medical Center, Birmingham, Alabama We retrospectively analyzed early and late results for two treatment strategies of significant coronary artery disease in 3 octogenarians seen in the last years. One hundred five patients or more years of age had percutaneous transluminal coronary angioplasty () and 5 had coronary artery bypass grafting (). The group differed from the group in having a greater proportion of women (71.4% versus 45.8%; p < 0.001); fewer patients with unstable angina (24.7% versus 33.6%; p < 0.04), acute myocardial infarction (11% versus 23%; p < 0.04), three-vessel coronary artery disease (% versus 56%; p < ), and a left ventricular ejection fraction less than or equal to 0. (% versus 21%; p < 0.008); and fewer vessels revascularized (1.2 ± 0.6 versus 3.5 ± 0.9; P < ). Hospital mortality was 8.57% after (9/14 failed ) and 5.8% after (4/14 emergent, 611 urgent, and 2/ elective). Hospital stay was 7 ± 0.9 days after and 14 ± 1.5 days after (p < 0.01). Independent predictors of hospital mortality obtained by multivariate analysis included failed and acute myocardial infarction ( group), a left ventricular ejection fraction equal to or less than 0., and acute myocardial infarction and emergency ( group). Survivors after both and showed a significant improvement in their New York Heart Association class. Actuarial survival at 5 years after was 55% and after it was 66% ip < 0.01). Cardiac event-free survival (deaths, myocardial infarction,, ) at 3 years was 61% after and 81% after (p < 0.01). In octogenarians, had a greater mortality and failure rate than in our younger patients. Overall morbidity was higher after than after (p < 0.05), given the nature and the severity of the increased risk factors in the group. (Ann Thome Surg ) A ccording to recent statistics [l], 3% of the US population in 19 is years of age or older. As the life expectancy of an average American is likely to improve beyond 75 years during this decade [2], we should expect a corresponding increase in the octogenarian population. It is obvious that this sector of the population is predisposed to the development of multisystem disorders, diminished vital organ function reserve, and some deterioration of physical and mental capacities. It is estimated that almost 18% of the octogenarians in the United States have significant coronary artery disease (CAD) [3], which remains a principal cause of their death [4]. Generally, there has been a reluctance on the part of the physicians, patients, and their relatives to rely on more aggressive interventions for their ischemic heart disease since these patients are believed to be a fragile populace. It appears that the decision to perform invasive procedures, eg angioplasty () or coronary artery bypass operation (), generally is guided by the severity and complexity of the disease and often is made too late [41, which contributes to a higher mortality and morbidity for these procedures in this age group [4, 5]. However, recent reports clearly indicate improved survival and benefits after and an accept- Accepted for publication April 11, Address reprint requests to Dr Kaul, Department of Cardiac Surgery, Princeton-Baptist Medical Center, 817 Princeton Ave, SW Suite 0, Birmingham, AL by The Society of Thoracic Surgeons able success rate after angioplasty in selected patients as compared with continued conventional medical therapy [4-6]. In this retrospective series we have analyzed results and benefits of the two therapeutic strategies ( and ) as used in octogenarians at our institution during the last years. Material and Methods Patients and Procedures We analyzed records of all octogenarians who received treatment for significant coronary artery disease confirmed by coronary angiogram between July 1982 and July 1993 at our hospital. The two treatment strategies used were primarily guided by coronary artery anatomy and the severity of the CAD. In some cases, treatment was also influenced by individual patient preference. One hundred five patients underwent percutaneous transluminal coronary angioplasty (), including 5 patients who initially were treated by thrombolytic therapy for an acute episode of myocardial infarction. Indications for these procedures, preoperative clinical details, and a summary of the vessels revascularized are outlined in Tables 1 through 3. Multiple-vessel angioplasty was performed in only patients, and multiple-lesion angioplasty of a single vessel in 6 patients. In patients, although dilatation of the main lesion was achieved, revascularization was incomplete /94/$7.00

2 14 KAUL ET AL VERSUS IN OCTOGENARIA Ann Thorac Surg Angioplasty was considered successful when the residual luminal dimension was 50% or less on angiography and there was clinical improvement without any major cardiac event or complication within 1 month. Failure to achieve 50% or less residual stenosis, dissection, an acute closure of a dilated lesion, clot formation, and an urgent need for to restore coronary circulation were considered "failed". Angioplasty was performed to open an occluded vessel after an acute myocardial infarction (AMI) in 11 patients as an emergent procedure. It was performed as an urgent procedure in 48 and as an elective procedure in 46 patients (Table 4). Emergency was performed for acute myocardial infarction (n = 14). An urgent (n = 1) was performed mainly for unstable angina, or evolving acute or resolving myocardial infarction. Elective (n = ) was performed for stable class IV angina (see Table 4). A carotid Doppler scan was performed in all cases, with the exception of cases that required emergency conveyance to the operating theater. A detailed systemic assessment was made in all cases and a Swan-Ganz catheter was placed before the induction of general anesthesia in most patients. Standard cardiopulmonary bypass with moderate hypothermia and cold blood cardioplegia was used for all patients. Since January 1989, cardioplegia has been delivered using a combined antegrade and retrograde route (it was done by antegrade route only before then). Postoperatively, dobutamine, nitroglycerine, and lowdose dopamine infusions were used as needed to improve cardiac output and reduce systemic vascular resistance. Prolonged ventilatory support was used when patients had hemodynamic instability, chronic obstructive pulmonary disease, a respiratory complication, or suboptimal neurologic recovery. Postoperatively, these patients required careful monitoring for longer periods and additional support for rehabilitation. Follow-up was complete in all patients by the end of June All patients were sent a questionnaire and then, if necessary, were contacted by telephone. Statistical Analysis Values are expressed as the mean ± standard error of the mean. Paired data were compared by using Student's t test, Table 1. Indications for or Indication Unstable angina Acute myocardial infarction Recurrent angina after previous: Recurrent ventricular dysrhythmias Stable NYHA class IV angina (n = 5) n % (n = 5) n % o = coronary artery bypass grafting; NYHA = New York Heart Association; = percutaneous transluminal coronary angioplasty. Table 2. Preoperative Patient Characteristics Patient Characteristic Mean age (y) Female CAD risk factors Hypertension Diabetes Smoking Family history Hyperlipidemia Clinical presentation Unstable angina AMI Cardiogenic shock IABP Stable class IV angina NYHA class I-II III-IV Previous Previous Coronary angiography Left main disease 3-vessel disease 2-vessel disease I-vessel disease Ostial stenosis LVEF > > <0. Vessels revascularized Incomplete revascularization Hospital stay (days) Systemic disease Hypothyroidism COPD PVD Internal carotid stenosis Parkinsonism Dementia Organic brain syndrome Macular degeneration (n = 5) n % 82.4 ± ± ± (n = 5) n % 84 ± p Value < < < < <0.001 < < < <0.01 < <0.008 < < <0.01 and unpaired data and proportional differences were compared using either the J! or Fisher's exact test for univariate analysis. The influence of all preoperative variables (see ± ± AMI = acute myocardial infarction; = coronary artery bypass grafting; CAD = coronary artery disease; COPD = chronic obstructive pulmonary disease; IABP = intraaortic balloon pump; LVEF = left ventricular ejection fraction; = not significant; NYHA = New York Heart Association; PVD = peripheral vascular disease.

3 Ann Thorac Surg 1994;58: KAUL ET AL 1421 VERSUS IN OCTOGENARIA Table 3. Early Results of in 5 Octogenarians" Failed Deaths No./No. of No./No. of Site of Lesions Vessels: % Patients: % Proximal 8/ / Peripheral (multilesion, 2/ / n = 6) Graft lesion 4/8 50 3/ Total 14/ / "One hundred thirty-one lesions were treated in 125 vessels (left main, 1; right osteal stenosis, 1; left anterior descending, 63; diagonal, 3; right coronary artery, 37; posterior descending, 1; circumflex coronary artery, 6; ramus intermedius, 2; obtuse marginals, 3; saphenous vein graft to right coronary artery, 6; and saphenous vein graft to the left anterior descending coronary artery, 2). = percutaneous transluminal coronary angioplasty. Tables 1-4), intraoperative variables (aortic cross-clamp time, bypass time, antegrade or retrograde cardioplegia), and postoperative variables on hospital mortality was examined using univariate analysis. Variables with a p value of approximately 0.1 or less were then entered into stepwise multivariate analysis. To detect independent predictors of hospital mortality after, the following variables were entered for the multivariate analysis: emergency, preoperative myocardial infarction, cardiogenic shock; left ventricular ejection fraction (LVEF) of 0. or less, triple-vessel CAD, hypertension, diabetes, chronic obstructive pulmonary disease, renal failure, and acute respiratory distress syndrome. Variables entered to detect independent predictors of hospital mortality after were failed resulting in acute myocardial infarction, emergency, graft, proximal coronary artery disease, female sex, congestive heart failure, preoperative acute myocardial infarction, and an LVEF less than or equal to 0.. The Cox proportional hazard model was used to detect independent predictors of late survival for the entire series (3 patients) as well as for both treatment modalities. The variables examined were: sex difference; presence or absence of hypertension; diabetes, chronic obstructive pulmonary disease; peripheral vascular disease; left main CAD; triple-vessel CAD; LVEF less than or equal to 0.; preoperative myocardial infarction; emergent, urgent, or elective revascularization; incomplete revascularization; postoperative myocardial infarction; and congestive heart failure. Actuarial analysis based on the Kaplan-Meier model was used to construct survival and event-free survival curves, which then were compared using Mantel's test. Statistical analysis was performed using Statistical Analysis Package (Stat Pac software); a p value of less than 0.05 was considered significant. Results Patient Characteristics Mean age for the entire series was 82 ± 0.7 years (range, to 92 years); 164 (54.2%) patients were female. In general, was preferred for patients with advanced CAD or multivessel disease and those with poor left ventricular function (see Table 2). As expected, a greater number of patients in the group had to be left with incomplete revascularization than in the group (p < ) (see Table 2). Overall hospital mortality was 8.57% after angieplasty and 5.85% after (not significant) (see Table 4). Hospital mortality for emergent revascularization by or was significantly higher than for urgent or elective revascularization within their own groups (see Table 4). Hospital mortality for elective revascularization by or was marginally greater than 2% (see Table 4). The influence of advancing age on mortality, morbidity, and longer-term survival in our medical center is outlined in Table 5. Patients less than years of age fared better than septuagenarians, who in turn fared better than did octogenarians. The failure rate for angioplasty was highest in octogenarians, but age had no influence on the initial success rate for the angioplasty in the remaining patients. The only independent predictor of hospital mortality after was acute myocardial infarction due to a failure of that procedure (p < 0.01). Other predictors of hospital mortality by univariate analysis were emergent and graft (Table 6). Multivariate analysis revealed that significant predictors of hospital mortality after were emergency (p < 0.001), preoperative acute myocardial infarction (p < 0.001), and an LVEF less than or equal to 0. (p < 0.001). Using univariate analysis alone, the predictors revealed were postoperative renal failure (p < ), triple-vessel CAD (p < 0.04), systemic hypertension (p < 0.01), and diabetes (p < 0.02) (Table 7). Morbidity and Complications The primary clinical and angiographic success rate for angioplasty was 88.7% (see Table 3). It was 89.75% for proximal lesions, 94.9% for peripheral lesions, and only 18% for total or subtotal occlusions (see Table 3). Overall Table 4. Hospital Mortality (n = 5) (n = 5) No. of No. of Procedure Deaths/No. % Deaths/No. % Emergent 3/ / Urgent No previous 2/40 3/88.4" 5.94" Previous 3/8 3/13 Elective 1/ b 2/ 2.2 b Total 9/ / a Comparison of emergent with urgent, I' < emergent with elective, I' < b Comparison of Elective = 3 to 7 days after cardiac catheterization, under stable conditions; Emergent = procedure performed within 1 to 6 hours after cardiac catheterization for cardiogenic shock or hemodynamic instability; Urgent = procedure performed within 48 hours after cardiac catheterization for impending or expanding ischemia (thallium scan) (these patients were maintained on intravenous heparin or nitroglycerin).

4 1422 KAULET AL VERSUS IN OCTOGENARIA Ann Thorac Surg Table 5. Influence of Age on Results of Revascularization (7/-7/93) With Backup for Operation Revascularization Result > y -79 Y < Y > Y -79 Y < Y No. of patients Hospital mortality (%) a b 1.6 c Early failure (%) d 4 Overall morbidity (%) e b 2 a Hospital stay (days) 14 :±: 1.5 1O:±:1.3 8:±: 2.6 7:±: 0.9 5:±: 0.6 3:±: year survival (%) d c a p < 0.001, comparison of -79 y with < y age group. b p < 0.05,comparison of > y with -79 y age group. C p < 0.01,comparison of -79 y with < y age group. d p < 0.01,comparison of > y with -79 y age group. e p < 0.001, comparison of > y with -79 y age group. f p < 0.05,comparison of -79 y with < y age group. = coronary artery bypass grafting; = percutaneous transluminal coronary angioplasty. morbidity due to postprocedural complications was higher after than after (54% versus 36.2%; p < 0.05) (Table 8). Incidence of major postoperative cerebrovascular accident was 1% after and 1.5% after (not significant), but the incidences of postoperative confusion and delirium clearly were higher after. Survivors after showed a significant improvement in their New York Heart Association class (3.2 ± 0.06 versus 1.5 ± 0.07; p < ). This improvement was also seen in patients with successful angioplasty (3 ± 0.9 versus 2.14 ± 0.1; p < 0.005). Late Deaths and Events Significant predictors of late mortality after (using the Cox model) were: preoperative myocardial infarction (p < ) and an LVEF less than or equal to 0. (p < ). Late mortality in the group was predominantly due to cardiac events (17/40) and less frequently due to coexistent systemic disorders (respiratory, 8/40; malignant disease, 3/40; cerebrovascular accident, 2/40; and multiorgan failure, /40). Late mortality after was mainly due to noncardiac events (eg, pneumonia, 4/24; cerebrovascular accident, 3/24; ruptured esophagus, 1/24; carcinoma of the esophagus, 3/24; chronic renal failure, 4/24). The remaining deaths were cardiac related. Actuarial survival rates at 1 month and 1, 3, 5, and years after were 94%, 89%, 77%, 66%, and 42%, respectively; after they were 91 %, 88%, 83%, 55%, and 21 %, respectively. The difference in survival curves between the two treatment modalities remained significant beyond 5 years (Fig 1). However, at 3 years postopera- Table 6. Predictors of Hospital Mortality in Octogenarians After Predictor Failed Emergent Graft = not significant; angioplasty. x Univariate p Value < <0.02 <0.01 Multivariate p Value <0.001 percutaneous transluminal coronary tively, cardiac event (cardiac death, redo,, myocardial infarction, and class IV angina) free survival was 81 % after and 61 % after (p < 0.01) (Fig 2). Of the 24 of 96 (25%) survivors after in whom restenosis developed, 14 underwent a repeat at an interval of 11 ± 2.4 months and underwent at an interval of 12 ± 8.4 months postoperatively (see Table 4). In the subset of patients requiring as an emergent procedure (Fig 3), patients with an LVEF less than or equal to 0. (Fig 4) and with preoperative acute myocardial infarction (Fig 5) had a high perioperative mortality and diminished long-term survival. Comment Recent United States population statistical surveys project a disproportionate growth in the octogenarian sector [2]. It is obvious that a number of octogenarians will present with clinical symptoms and complications of ischemic heart disease, which remains a principal cause of death in this age group [4]. The demographic and disease pattern of CAD in this age group may show interesting variation [7-]. In this series, as well as in previous reports, women comprised a greater proportion of CAD patients than Table 7. Predictors of Hospital Mortality in Octogenarians After Univariate Multivariate Predictor X 2 p Value p Value Emergency 14 <0.001 <0.001 Preop AMI 9.2 <0.008 <0.001 LVEF < < <0.001 Postop renal failure 50 < Redo 7.47 <0.01 Triple-vessel CAD 5.8 <0.04 Hypertension 5.6 <0.04 Diabetes 5.4 <0.02 AMI = acute myocardial infarction; = coronary artery bypass grafting; CAD = coronary artery disease; LVEF = left ventricular ejection fraction; = not significant; Postop ~ postoperative; Preop = preoperative.

5 Ann Thorac Surg KAUL ET AL 1423 VERSUS IN OCTOGENARIA Table 8. Incidence of Major Complications or Events After or in Octogenarians (n = 5) (n = 5) P Complication/Event n % n % Value Cardiac Respiratory <0.001 Gastrointestinal Renal failure Neurologic Major CVA Others Wound infections Overall morbidity = coronary artery bypass grafting; CVA = cerebrovascular accident; = not significant; = percutaneous transluminal coronary angioplasty. expected []. Owing to a general reluctance to use invasive procedures in this population of fragile individuals, ischemic heart disease often is allowed to progress to an advanced stage. A number of previous studies have shown a greater incidence of left main disease, triple-vessel CAD, ventricular dysrhythmias, and dysfunction in this age group [9, 11]. In view of advanced CAD, multisystem disorders, and diminished vital organ function reserves, these individuals are less capable of withstanding the stress of major interventional procedures [5]. Therefore, less extensive procedures such as thrombolytic therapy and angioplasty often have been considered more attractive options, although not as beneficial or as lasting as coronary artery bypass [12]. Thrombolytic therapy has been used successfully to thwart an acute ischemic episode, but its early patency rate clearly is inferior to that obtained after a successful angioplasty [13]. Thrombolytic therapy also carries a risk of hemorrhagic episodes, especially cerebrovascular accidents [131, and for this reason [14] it was not used frequently in this series. Data regarding the use and the success of angioplasty in this age group are limited, and very few studies have evaluated the long-term results of the invasive treatment strategies. Angioplasty clearly gives better results than thrombolytic therapy in an acute situation and has been preferred if available [13]. However, previous reports have demonstrated a % to 35% closure rate within 6 months after a successful [7, 15]. It is generally the most suitable therapeutic option for singlevessel disease [7]. A single-vessel angioplasty was performed in.95% of our patients, which is comparable with another recently published series [12]. Little and associates [] have reported a 96% success rate for multiple-lesion, single-vessel angioplasty. In two recent reports, multiple angioplasty was attempted in almost one-third of the patients [6, 15]. In octogenarians, the primary clinical and angiographic success rate of has been lower than in younger patients. In our series the primary clinical as well as the angiographic success rate after was 88.7%, which was within the range (74%-93%) for this age group [12, 15]. Primary success after angioplasty also depends on the anatomic site and the characteristics of the lesions. Earlier reports showed a lower success rate for circumflex than for right or left anterior descending artery lesions []. In general, left main coronary stenosis, ostial stenoses, and more proximal lesions have a lower success rate than do more peripheral lesions. As in other age groups, graft stenoses in general are expected to have a lower success rate than primary lesions. In our series, primary success for the proximal lesions (89.75%) was inferior to that for the more peripheral lesions (94.9%) and right coronary arterial lesions had a marginally lower primary success rate than other vessels. In our series, acute myocardial infarction due to failed developed in 7.6% and required emergency operation, which was within the range (2.7% to 7.8%) described earlier [7]. Twenty-five percent of our patients 0 0/0 Survival CASG L.-,...,.-,...,...,.""T"""T"""T'""T'"'T"""'T"""'T"""'T""T""T"",...,...T"'""T"'""T"'""r-,...,..,...,... PlCA Fig 1. Actuarial survival ± % confidence limits after coronary artery bypass grafting () versus percutaneous transluminal coronary angioplasty () in octogenarians. (CL = confidence limit; OP = operaiioe.)

6 1424 KAUL ET AL VERSUS IN OCTOGENARIA Ann Thorac Surg Fig 2. Cardiac event-freesurvival (freedom from further coronary artery bypass grafting (), percutaneous transluminal coronary angioplasty (), myocardial infarction, or death) for versus. Cardiac Event Free % Survival ~ P T C A PlCA had early stenosis after successful angioplasty, as described earlier [7, 15]. Recent reports indicate that although coronary artery bypass operation in octogenarians generally was performed for more advanced disease [61, it clearly resulted in longer survival [7] and longer symptomatic relief than did angioplasty [7]. In our similar experience, hospital mortality after was no higher than after angioplasty. Some authors have reported a clearly lower perioperative mortality for than for [61, but in general, most reports indicate that perioperative mortality after both procedures ranges between 2% and % [4, 11, 12, 14-17]. These invasive procedures were associated with higher mortality when they were performed for unstable angina, acute myocardial infarction, or cardiogenic shock. However, it appears that when elective was performed in octogenarians who were stable preoperatively, the perioperative mortality ranged between 2% and 3% [4]. Due to the severe nature of the coronary artery disease and the presence of a number of coexisting disorders, 43% to 75% of the survivors after have been known to experience some postoperative complication [11, 17]. Some of these may have contributed to the high mortality of 15% to 41% within 3 months after [11, 17]. As reported earlier [6] the survival difference before 5 years between the and groups was almost negligible, but the cardiac-related event-free survival rate at that interval was clearly superior after. As described by others [4, 5, 16] the important predictors of perioperative mortality in this series were: emergency, an LVEF of 0., and operation for acute myocardial infarction. Others have reported reintubation and ventilation [17], ventricular dysrhythmias, and reexploration for bleeding [5] as important predictors of perioperative mortality after. In this series only 2 patients were explored for postoperative hemorrhage after, and both survived. Gentle handling of the tissues and meticulous hemostasis are absolutely essential for a smooth postoperative recovery in this Fig 3. Cumulative survival of octogenarians requiring emergency coronary artery bypass grafting () versus nonemergency up to years. A risk factor of emergent was not significant using the Cox hazard model due to small numbers. 0 % Survival 50 40, EMERGENCY -- URGENT I ELECTIVE

7 Ann Thorac Surg 1994;58: KAUL ET AL 1425 VERSUS IN OCTOGENARIA % Survival lvefs. -- lvef>% Deaths lvef<% - l V E F ~ 3 0 % HAZARD RA TE X 00 (:I: % cc) A j l B 1j l2 1 ~ Fig 4_ (A) Cumulative survival ± % confidence limits of the subset of patients with a left ventricle ejection fraction of 0. or less (LVEF) requiring coronary artery bypass grafting () versus other patients. (B) Subset of patients with LVEF <0. had a higher cardiac-related death rate in perioperative period and later (6-7 years). (CL = confidence limits.) age group. In our series the most important predictor of hospital mortality after was acute myocardial infarction after a failed procedure. The incidence of failure and postprocedure acute myocardial infarction is generally higher in this age group (ranging between 1% and 7.8%) than in younger patients []. It is our impression that invasive procedures such as and sometimes are postponed beyond the appropriate time in octogenarians out of fear for their age and fragility. In our series, elective was performed in 45% and elective in 43.8%, before they suffered a significant deterioration in New York Heart Association class. Late intervention in these fragile patients with diminished reserves likely accounts for higher mortality and morbidity. Patient selection for or generally is guided by the severity of the coronary artery disease and lesion characteristics. In this age group especially, individual patient preference for one or the other treatment modality is also given important consideration. With a progtessive improvement in technique, angioplasty has % Survival PRE OP AMI -- WITHOUT AMI Deaths WITH PRE OP ACUTEMI -- WITHOUT AMI HAZARD RATE X 00 (:t % ClI A ~l ts s 8 9 B Fig 5. (A) Cumulative survival ± % confidence limits of the subset of octogenarians who required coronary artery bypass grafting () for acute myocardial infarction (AMI) versus the remaining patients. (B) The subset of octogenarians requiring for acute myocardial infarction (MI) had a higher perioperative and late mortality than the remaining patients. (CL = confidence limits.)

8 1426 KAUL ET AL VERSUS IN OCTOGENARIA Ann Thorac Surg been performed successfully for multiple-vessel disease and for more proximal and difficult lesions. However, % to 35% of vessels may have restenosis within 6 months after angioplasty [7, 15]. Although the incidence is not directly related to old age, this has been considered as a significant disadvantage of this procedure. Coronary artery bypass operation was preferred in twothirds of our patients. We did not use thrombolytic therapy due to a higher risk of stroke associated with it for this age group [18]. Early intervention may reduce perioperative mortality in these patients, but postoperative morbidity is likely to remain high, demanding a greater amount of care for a successful outcome after operation. We believe this approach could help a number of octogenarians who lead an independent existence and are expected to live for another 7 to 8 years [19], after having reached years of age. This study shows that octogenarians may receive substantative benefits through myocardial revascularization, especially with. As expected, myocardial revascularization did not improve the quality of life of our octogenarians to the same extent that it did for our younger patients. Recently, we have extended the use of multivessel and multilesion angioplasty to more discrete and peripheral lesions, especially for patients with retarded physical and mental capabilities and for patients with uncompensated medical illness. We prefer for patients with complex coronary anatomy in patients with well-compensated medical conditions. We are grateful to Mrs Sandra Siebert for completing the list of octogenarians and also to Ms Melody Hamrick for secretarial help in preparation of the manuscript. References 1. US Bureau of the Census: statistical abstract of the United States 19, ed 1. Washington, DC: US Government Printing Office. 2. Bureau of Census. Projection of the population of the United States by age, sex and race, Washington, DC: Government Printing Office, 1984:Current Population Series P-25 No National nursing home survey. Hyattsvik MS: National Center for Health Statistics, Ko W, Gold JP, Lazzaro R, et a1. Survival analysis of octogenarian patients with coronary artery disease managed by elective coronary artery bypass surgery versus conventional medical therapy. Circulation 1992;86(Suppl 2): Ko W, Krieger KH, Lazenby WD, et a1.coronary artery bypass grafting in one hundred consecutive octogenarian patients. J Thorac Cardiovasc Surg 1991;2: Mick MJ, Simpfendorfer C, Arnold AZ, Piedmonte M, Lytle BW. Early and late results of coronary angioplasty and bypass in octogenarians. Am J Cardiol 1991;68: Gold S, Wong WF, Schatz II, Blanchette PL. Invasive treatment for coronary artery disease in the elderly. Arch Int Med 1991;151: Naunheim KS, Kern MI, McBride LR. Coronary artery bypass surgery in patients aged years or older. Am J Cardiol 1987;59: Gersh BI, Kronmal RA, Frye RL, et a1.coronary arteriography and coronary artery bypass surgery morbidity and mortality in patients over 65 years and older: a report from CASSo Circulation 1983;67: Little T, Milner M, Pichard AD, Mukherjee D, Lindsay J Jr. A comparison of multi-lesion percutaneous transluminal angieplasty in elderly patients over years and younger subjects. Am Heart J 1991;122: Mullany CJ, Darling GE, Pluth JR, Orzulak TA, Schaff HV. Early and late results after isolated coronary artery bypass surgery in 159 patients aged years and older. Circulation 19;82(SuppI4): Santana JO, Haft JI, La Marche, Goldstein JE. Coronary angioplasty in patients eighty years or older. Am Heart J 1992;124: Pringle SD, Boon NA. Immediate coronary angioplasty for acute myocardial infarction, safe and effective but not available in most centers. Br Med J 1993;6: Rich MW, Sandza JG, Kleiger RE, Connors JP. Cardiac operation in patients over years of age. J Thorac Cardiovasc Surg 1985;: [eroudi MO, Kleiman, Monor ST. Percutaneous transluminal coronary angioplasty in octogenarians. Am J Intern Med 19;113: Tsai TP, Nessim S, Kass RM. Morbidity and mortality after coronary artery bypass in octogenarians. Ann Thorac Surg 1991;51: Edmunds LH, Stephenson LW, Edie RN, Ratcliffe MB. Open heart surgery in octogenarians. N Engl J Med 1988;319: The Gusto Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329: National Center for Health Statistics United States Life Tables: US decennial life tables for 1979 to Vol 1, No. 1. Washington, DC: Government Printing Office, 1985:Duss Publication NO (Phs)

Importance of the third arterial graft in multiple arterial grafting strategies

Importance of the third arterial graft in multiple arterial grafting strategies Research Highlight Importance of the third arterial graft in multiple arterial grafting strategies David Glineur Department of Cardiovascular Surgery, Cliniques St Luc, Bouge and the Department of Cardiovascular

More information

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such

More information

ORIGINAL ARTICLE. Peripheral Vascular Disease and Outcomes Following Coronary Artery Bypass Graft Surgery

ORIGINAL ARTICLE. Peripheral Vascular Disease and Outcomes Following Coronary Artery Bypass Graft Surgery ORIGINAL ARTICLE Peripheral Vascular Disease and Outcomes Following Coronary Artery Bypass Graft Surgery Ted Collison, MD; J. Michael Smith, MD; Amy M. Engel, MA Hypothesis: There is an increased operative

More information

Coronary atherosclerotic heart disease remains the number

Coronary atherosclerotic heart disease remains the number Twenty-Year Survival After Coronary Artery Surgery An Institutional Perspective From Emory University William S. Weintraub, MD; Stephen D. Clements, Jr, MD; L. Van-Thomas Crisco, MD; Robert A. Guyton,

More information

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki Hong, MD. PhD on behalf of the IVUS-XPL trial investigators

More information

The operative mortality rate after redo valvular operations

The operative mortality rate after redo valvular operations Clinical Outcomes of Redo Valvular Operations: A 20-Year Experience Naoto Fukunaga, MD, Yukikatsu Okada, MD, Yasunobu Konishi, MD, Takashi Murashita, MD, Mitsuru Yuzaki, MD, Yu Shomura, MD, Hiroshi Fujiwara,

More information

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell

More information

Severe left ventricular (LV) dysfunction caused by

Severe left ventricular (LV) dysfunction caused by Revascularization in Severe Ventricular Dysfunction (15% < LVEF < 30%): A Comparison of Bypass Grafting and Percutaneous Intervention Koichi Toda, MD, PhD, Karen Mackenzie, MD, Mandeep R. Mehra, MD, Charles

More information

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME

More information

Emergency surgery in acute coronary syndrome

Emergency surgery in acute coronary syndrome Emergency surgery in acute coronary syndrome Teerawoot Jantarawan Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

More information

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20. Journal of the American College of Cardiology Vol. 35, No. 5, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00546-5 CLINICAL

More information

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang

More information

Management during Reoperation of Aortocoronary Saphenous Vein Grafts with Minimal Atherosclerosis by Angiography

Management during Reoperation of Aortocoronary Saphenous Vein Grafts with Minimal Atherosclerosis by Angiography Management during Reoperation of ortocoronary Saphenous Vein Grafts with therosclerosis by ngiography William G. Marshall, Jr., M.D., Jeffrey Saffitz, M.D., and Nicholas T. Kouchoukos, M.D. STRCT The proper

More information

Ischemic Ventricular Septal Rupture

Ischemic Ventricular Septal Rupture Ischemic Ventricular Septal Rupture Optimal Management Strategies Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Disclosures Abbott Mitraclip Royalties Johnson & Johnson Proctor

More information

The MAIN-COMPARE Study

The MAIN-COMPARE Study Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:

More information

Unprotected LM intervention

Unprotected LM intervention Unprotected LM intervention Guideline for COMBAT Seung-Jung Park, MD, PhD Professor of Internal Medicine, Seoul, Korea Current Recommendation for unprotected LMCA Stenosis Class IIb C in ESC guideline

More information

Setting The setting was a hospital. The economic study was carried out in Australia.

Setting The setting was a hospital. The economic study was carried out in Australia. Coronary artery bypass grafting (CABG) after initially successful percutaneous transluminal coronary angioplasty (PTCA): a review of 17 years experience Barakate M S, Hemli J M, Hughes C F, Bannon P G,

More information

Reoperative Coronary Artery Bypass Grafting: Analysis of Early And Late Outcomes

Reoperative Coronary Artery Bypass Grafting: Analysis of Early And Late Outcomes Original Article Reoperative Coronary Artery Bypass Grafting: Analysis of Early And Late Outcomes AR Jodati, MA Yousefnia From Department of Cardiothoracic Surgery, Madani Heart Hospital, Tabriz University

More information

The MAIN-COMPARE Registry

The MAIN-COMPARE Registry Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:

More information

I internal mammary artery (IMA) is widely accepted as

I internal mammary artery (IMA) is widely accepted as Routine Use of the Left Internal Mammary Artery Graft in the Elderly Timothy J. Gardner, MD, Peter S. Greene, MD, Mary F. Rykiel, RN, William A. Baumgartner, MD, Duke E. Cameron, MD, Alfred S. Casale,

More information

Influence of Planned Six-Month Follow-Up Angiography on Late Outcome After Percutaneous Coronary Intervention A Randomized Study

Influence of Planned Six-Month Follow-Up Angiography on Late Outcome After Percutaneous Coronary Intervention A Randomized Study Journal of the American College of Cardiology Vol. 38, No. 4, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01476-0 Influence

More information

Distal Coronary Artery Dissection Following Percutaneous Transluminal Coronary Angioplasty

Distal Coronary Artery Dissection Following Percutaneous Transluminal Coronary Angioplasty Distal Coronary rtery Dissection Following Percutaneous Transluminal Coronary ngioplasty Douglas. Murphy, M.D., Joseph M. Craver, M.D., and Spencer. King 111, M.D. STRCT The most common cause of acute

More information

Does the Presence of Preoperative Mild or Moderate Coronary Artery Disease Affect the Outcomes of Lung Transplantation?

Does the Presence of Preoperative Mild or Moderate Coronary Artery Disease Affect the Outcomes of Lung Transplantation? Does the Presence of Preoperative Mild or Moderate Coronary Artery Disease Affect the Outcomes of Lung Transplantation? Cliff K. Choong, FRACS, Bryan F. Meyers, MD, Tracey J. Guthrie, BSN, Elbert P. Trulock,

More information

Preoperative risk factors for carotid endarterectomy: Defining the patient at high risk

Preoperative risk factors for carotid endarterectomy: Defining the patient at high risk Preoperative risk factors for carotid endarterectomy: Defining the patient at high risk Amy B. Reed, MD, a Peter Gaccione, MA, b Michael Belkin, MD, b Magruder C. Donaldson, MD, b John A. Mannick, MD,

More information

SUPPLEMENTAL MATERIAL

SUPPLEMENTAL MATERIAL SUPPLEMENTAL MATERIAL Table S1: Number and percentage of patients by age category Distribution of age Age

More information

Coronary Artery Disease: Revascularization (Teacher s Guide)

Coronary Artery Disease: Revascularization (Teacher s Guide) Stephanie Chan, M.D. Updated 3/15/13 2008-2013, SCVMC (40 minutes) I. Objectives Coronary Artery Disease: Revascularization (Teacher s Guide) To review the evidence on whether percutaneous coronary intervention

More information

EACTS Adult Cardiac Database

EACTS Adult Cardiac Database EACTS Adult Cardiac Database Quality Improvement Programme List of changes to Version 2.0, 13 th Dec 2018, compared to version 1.0, 1 st May 2014. INTRODUCTORY NOTES This document s purpose is to list

More information

Coronary artery bypass grafting (CABG) is a temporary treatment for a

Coronary artery bypass grafting (CABG) is a temporary treatment for a Surgery for Acquired Cardiovascular Disease Influence of patient characteristics and arterial grafts on freedom from coronary reoperation Joseph F. Sabik III, MD, a Eugene H. Blackstone, MD, a,b A. Marc

More information

The Influence of Previous Percutaneous Coronary Intervention in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting

The Influence of Previous Percutaneous Coronary Intervention in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting Original Article The Influence of Previous Percutaneous Coronary Intervention in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting Toshihiro Fukui, MD, Susumu Manabe, MD, Tomoki Shimokawa, MD,

More information

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Julinda Mehilli, MD Deutsches Herzzentrum Technische Universität Munich Germany ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Background Left main

More information

Complete Proximal Occlusion of All Three Main Coronary Arteries Complicated With a Left Main Coronary Aneurysm: A Case Report

Complete Proximal Occlusion of All Three Main Coronary Arteries Complicated With a Left Main Coronary Aneurysm: A Case Report J Cardiol 2004 Nov; 44 5 : 201 205 Complete Proximal Occlusion of All Three Main Coronary Arteries Complicated With a Left Main Coronary Aneurysm: A Case Report Takatoshi Hiroshi Akira Takahiro Masayasu

More information

Cover Page. The handle holds various files of this Leiden University dissertation

Cover Page. The handle  holds various files of this Leiden University dissertation Cover Page The handle http://hdl.handle.net/1887/21543 holds various files of this Leiden University dissertation Author: Dharma, Surya Title: Perspectives in the treatment of cardiovascular disease :

More information

Analysis of Mortality Within the First Six Months After Coronary Reoperation

Analysis of Mortality Within the First Six Months After Coronary Reoperation Analysis of Mortality Within the First Six Months After Coronary Reoperation Frans M. van Eck, MD, Luc Noyez, MD, PhD, Freek W. A. Verheugt, MD, PhD, and Rene M. H. J. Brouwer, MD, PhD Departments of Thoracic

More information

CORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW

CORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP: #43 Coronary Artery Bypass Graft (CABG):

More information

The increase in the lifespan of the western population

The increase in the lifespan of the western population Outcome After Aortic Valve Replacement in Octogenarians Bruno Chiappini, MD, Nicola Camurri, MD, Antonio Loforte, MD, Luca Di Marco, MD, Roberto Di Bartolomeo, MD, and Giuseppe Marinelli, MD Department

More information

The number of elderly patients is increasing at an

The number of elderly patients is increasing at an Arterial Grafting Results in Reduced Operative Mortality and Enhanced Long-Term Quality of Life in Octogenarians Paul A. Kurlansky, MD, Donald B. Williams, MD, Ernest A. Traad, MD, Roger G. Carrillo, MD,

More information

Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroscore

Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroscore Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroscore Marzia Leacche, MD, John G. Byrne, MD, Natalia S. Solenkova,

More information

6 GERIATRIC CARDIAC SURGERY

6 GERIATRIC CARDIAC SURGERY 6 GERIATRIC CARDIAC SURGERY Nicola Francalancia, MD; Joseph LoCicero III, MD, FACS* Cardiovascular disease is the leading cause of death in the United States; 84% of deaths from cardiovascular disease

More information

TSDA ACGME Milestones

TSDA ACGME Milestones TSDA ACGME Milestones Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short

More information

SURGICAL MYOCARDIAL REVASCULARIZATION: ARTERIAL VS VENOUS GRAFTS, SINGLE VS MULTIPLE GRAFTS?

SURGICAL MYOCARDIAL REVASCULARIZATION: ARTERIAL VS VENOUS GRAFTS, SINGLE VS MULTIPLE GRAFTS? SURGICAL MYOCARDIAL REVASCULARIZATION: ARTERIAL VS VENOUS GRAFTS, SINGLE VS MULTIPLE GRAFTS? Luigi Martinelli Chief, Dept. of Surgery Istituto Clinico Ligure di Alta Specialità RAPALLO During 1987 2006,

More information

University of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives

University of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives University of Florida Department of Surgery CardioThoracic Surgery VA Learning Objectives This service performs coronary revascularization, valve replacement and lung cancer resections. There are 2 faculty

More information

Cardiogenic Shock. Carlos Cafri,, MD

Cardiogenic Shock. Carlos Cafri,, MD Cardiogenic Shock Carlos Cafri,, MD SHOCK= Inadequate Tissue Mechanisms: Perfusion Inadequate oxygen delivery Release of inflammatory mediators Further microvascular changes, compromised blood flow and

More information

Prolonged Oral Morphine Therapy for Severe Angina Pectoris

Prolonged Oral Morphine Therapy for Severe Angina Pectoris Vol. 19 No. 5 May 2000 Journal of Pain and Symptom Management 393 Clinical Note Prolonged Oral Morphine Therapy for Severe Angina Pectoris Meir Mouallem, MD, Eli Schwartz, MD, and Zvi Farfel, MD Department

More information

Supplementary Table S1: Proportion of missing values presents in the original dataset

Supplementary Table S1: Proportion of missing values presents in the original dataset Supplementary Table S1: Proportion of missing values presents in the original dataset Variable Included (%) Missing (%) Age 89067 (100.0) 0 (0.0) Gender 89067 (100.0) 0 (0.0) Smoking status 80706 (90.6)

More information

Myocardial enzyme release after standard coronary artery bypass grafting

Myocardial enzyme release after standard coronary artery bypass grafting Cardiopulmonary Support and Physiology Schachner et al Myocardial enzyme release in totally endoscopic coronary artery bypass grafting on the arrested heart Thomas Schachner, MD, a Nikolaos Bonaros, MD,

More information

PERIOPERATIVE MYOCARDIAL INFARCTION THE ANAESTHESIOLOGIST'S VIEW

PERIOPERATIVE MYOCARDIAL INFARCTION THE ANAESTHESIOLOGIST'S VIEW PERIOPERATIVE MYOCARDIAL INFARCTION THE ANAESTHESIOLOGIST'S VIEW Bruce Biccard Perioperative Research Group, Department of Anaesthetics 18 June 2015 Disclosure Research funding received Medical Research

More information

Intraoperative application of Cytosorb in cardiac surgery

Intraoperative application of Cytosorb in cardiac surgery Intraoperative application of Cytosorb in cardiac surgery Dr. Carolyn Weber Heart Center of the University of Cologne Dept. of Cardiothoracic Surgery Cologne, Germany SIRS & Cardiopulmonary Bypass (CPB)

More information

Is bypass surgery needed for elderly patients with LMT disease? From the surgical point of view

Is bypass surgery needed for elderly patients with LMT disease? From the surgical point of view CCT 2003 (Kobe) Is bypass surgery needed for elderly patients with LMT disease? From the surgical point of view Hitoshi Yaku, MD, PhD Department of Cardiovascular Surgery Kyoto Prefectural University of

More information

OPCAB IS NOT BETTER THAN CONVENTIONAL CABG

OPCAB IS NOT BETTER THAN CONVENTIONAL CABG OPCAB IS NOT BETTER THAN CONVENTIONAL CABG Harold L. Lazar, M.D. Harold L. Lazar, M.D. Professor of Cardiothoracic Surgery Boston Medical Center and the Boston University School of Medicine Boston, MA

More information

Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication vs Benefit? Mortality? Morbidity?

Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication vs Benefit? Mortality? Morbidity? Preoperative intraaortic balloon counterpulsation in high-risk CABG Stefan Klotz, M.D. Preoperative IABP in high-risk CABG Questions?? Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication

More information

The development of cardiogenic shock portends an extremely poor prognosis. Cardiogenic Shock: A Lethal Complication of Acute Myocardial Infarction

The development of cardiogenic shock portends an extremely poor prognosis. Cardiogenic Shock: A Lethal Complication of Acute Myocardial Infarction TREATMENT UPDATE Cardiogenic Shock: A Lethal Complication of Acute Myocardial Infarction David R. Holmes, Jr, MD Mayo Graduate School of Medicine, Mayo Clinic, Rochester, MN Cardiogenic shock is a serious

More information

Aortocoronary Bypass in the Treatment of Left Main Coronary Artery Stenosis

Aortocoronary Bypass in the Treatment of Left Main Coronary Artery Stenosis Aortocoronary Bypass in the Treatment of Left Main Coronary Artery Stenosis W. C. Alford, Jr., M.D., I. J. Shaker, M.D., C. S. Thomas, Jr., M.D., W. S. Stoney, M.D., G. R. Burrus, M.D., and H. L. Page,

More information

Rationale for Prophylactic Support During Percutaneous Coronary Intervention

Rationale for Prophylactic Support During Percutaneous Coronary Intervention Rationale for Prophylactic Support During Percutaneous Coronary Intervention Navin K. Kapur, MD, FACC, FSCAI Assistant Director, Interventional Cardiology Director, Interventional Research Laboratories

More information

Declaration of conflict of interest NONE

Declaration of conflict of interest NONE Declaration of conflict of interest NONE Claudio Muneretto MD, PhD Director of Division of Cardiac Surgery University of Brescia Medical School Italy Hybrid Chymera Different features and potential advantages

More information

Management of High-Risk CAD : Surgeons Perspective

Management of High-Risk CAD : Surgeons Perspective Management of High-Risk CAD : Surgeons Perspective Steven F. Bolling, M.D. Professor of Cardiac Surgery University of Michigan Conflict : Cardiac Surgeon! High Risk CABG 77 year old with prior large anterior

More information

Percutaneous Coronary Interventions Without On-site Cardiac Surgery

Percutaneous Coronary Interventions Without On-site Cardiac Surgery Percutaneous Coronary Interventions Without On-site Cardiac Surgery Hassan Al Zammar, MD,FESC Consultant & Interventional Cardiologist Head of Cardiology Department European Gaza Hospital Palestine European

More information

CPT Code Details

CPT Code Details CPT Code 93572 Details Code Descriptor Intravascular Doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically

More information

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Helder Dores, Luís Bronze Carvalho, Ingrid Rosário, Sílvio Leal, Maria João

More information

PROMUS Element Experience In AMC

PROMUS Element Experience In AMC Promus Element Luncheon Symposium: PROMUS Element Experience In AMC Jung-Min Ahn, MD. University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea PROMUS Element Clinical

More information

On-Pump vs. Off-Pump CABG: The Controversy Continues. Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery

On-Pump vs. Off-Pump CABG: The Controversy Continues. Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery On-Pump vs. Off-Pump CABG: The Controversy Continues Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery On-pump vs. Off-Pump CABG: The Controversy Continues Conflict

More information

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO! Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO! Young-Hak Kim, MD, PhD Heart Institute, University of Ulsan College of Medicine Asan Medical Center,

More information

Outcome of Coronary Bypass Surgery Versus Coronary Angioplasty in Diabetic Patients With Multivessel Coronary Artery Disease

Outcome of Coronary Bypass Surgery Versus Coronary Angioplasty in Diabetic Patients With Multivessel Coronary Artery Disease 10 CLINICAL STUDIES JACC Vol. 31, No. 1 INTERVENTIONAL CARDIOLOGY Outcome of Coronary Bypass Surgery Versus Coronary Angioplasty in Diabetic Patients With Multivessel Coronary Artery Disease WILLIAM S.

More information

Choice of Hemodynamic Support During Coronary Artery Bypass Surgery for Prevention of Stroke

Choice of Hemodynamic Support During Coronary Artery Bypass Surgery for Prevention of Stroke The Journal of The American Society of Extra-Corporeal Technology Choice of Hemodynamic Support During Coronary Artery Bypass Surgery for Prevention of Stroke Yasuyuki Shimada, MD, PhD;* Hitoshi Yaku,

More information

Left Subclavian Artery Stenosis in Coronary Artery Bypass: Prevalence and Revascularization Strategies

Left Subclavian Artery Stenosis in Coronary Artery Bypass: Prevalence and Revascularization Strategies Left Subclavian Artery Stenosis in Coronary Artery Bypass: Prevalence and Revascularization Strategies Ho Young Hwang, MD, Jin Hyun Kim, MD, Whal Lee, MD, PhD, Jae Hyung Park, MD, PhD, and Ki-Bong Kim,

More information

Coral Trials: A personal experience that challenges its results in patients with uncontrolled blood pressure.

Coral Trials: A personal experience that challenges its results in patients with uncontrolled blood pressure. Coral Trials: A personal experience that challenges its results in patients with uncontrolled blood pressure.. Dr. Javier Ruiz Aburto, FACS, FICS Assistant Professor Ponce School of Medicine Puerto Rico

More information

Randomized comparison of single versus double mammary coronary artery bypass grafting: 5 year outcomes of the Arterial Revascularization Trial

Randomized comparison of single versus double mammary coronary artery bypass grafting: 5 year outcomes of the Arterial Revascularization Trial Randomized comparison of single versus double mammary coronary artery bypass grafting: 5 year outcomes of the Arterial Revascularization Trial Embargoed until 10:45 a.m. CT, Monday, Nov. 14, 2016 David

More information

Journal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20.

Journal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20. Journal of the American College of Cardiology Vol. 37, No. 2, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)01133-5 Coronary

More information

Chapter 4 Section 9.1

Chapter 4 Section 9.1 Surgery Chapter 4 Section 9.1 Issue Date: August 26, 1985 Authority: 32 CFR 199.4(c)(2) and (c)(3) 1.0 CPT 1 PROCEDURE CODES 33010-33130, 33140, 33141, 33200-37186, 37195-37785, 92950-93272, 93303-93581,

More information

Clinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center

Clinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center Aging Research Volume 2013, Article ID 471026, 4 pages http://dx.doi.org/10.1155/2013/471026 Clinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at

More information

Aortic Valve Replacement or Heart Transplantation in Patients With Aortic Stenosis and Severe Left Ventricular Dysfunction

Aortic Valve Replacement or Heart Transplantation in Patients With Aortic Stenosis and Severe Left Ventricular Dysfunction Aortic Valve Replacement or Heart Transplantation in Patients With Aortic Stenosis and Severe Left Ventricular Dysfunction L.S.C. Czer, S. Goland, H.J. Soukiasian, S. Gallagher, M.A. De Robertis, J. Mirocha,

More information

Ultrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism

Ultrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Interventional procedure consultation document Ultrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism A pulmonary embolism (PE) is

More information

Counterpulsation. John N. Nanas, MD, PhD. Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece

Counterpulsation. John N. Nanas, MD, PhD. Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece John N. Nanas, MD, PhD Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece History of counterpulsation 1952 Augmentation of CBF Adrian and Arthur Kantrowitz, Surgery 1952;14:678-87

More information

Left Internal Mammary Artery to the Left Anterior Descending Artery: Effect on Morbidity and Mortality and Reasons for Nonusage

Left Internal Mammary Artery to the Left Anterior Descending Artery: Effect on Morbidity and Mortality and Reasons for Nonusage Left Internal Mammary Artery to the Left Anterior Descending Artery: Effect on Morbidity and Mortality and Reasons for Nonusage Shishir Karthik, FRCS, Arun K. Srinivasan, FRCS, Antony D. Grayson, BS, Mark

More information

FFR in Multivessel Disease

FFR in Multivessel Disease FFR in Multivessel Disease April, 26 2013 Coronary Physiology in the Catheterization Laboratory Location: European Heart House, Nice, France Pim A.L. Tonino, MD, PhD Hartcentrum, Eindhoven, the Netherlands

More information

ST-elevation myocardial infarctions (STEMIs)

ST-elevation myocardial infarctions (STEMIs) Guidelines for Treating STEMI: Case-Based Questions As many as 25% of eligible patients presenting with STEMI do not receive any form of reperfusion therapy. The ACC/AHA guidelines highlight steps to improve

More information

Chapter 4 Section 9.1

Chapter 4 Section 9.1 Surgery Chapter 4 Section 9.1 Issue Date: August 26, 1985 Authority: 32 CFR 199.4(c)(2) and (c)(3) 1.0 CPT 1 PROCEDURE CODES 33010-33130, 33140, 33141, 33361-33369, 33200-37186, 37195-37785, 92950-93272,

More information

and Paul C. Taylor, M.D. ORIGINAL ARTICLES

and Paul C. Taylor, M.D. ORIGINAL ARTICLES ORIGINAL ARTICLES Trends in Selection and Results of Coronary Artery Reoperations Floyd D. Loop, M.D., Bruce W. Lytle, M.D., Carl C. Gill, M.D., Leonard A. R. Golding, M.D., Delos M. Cosgrove, M.D., and

More information

and Coronary Artery Surgery George M. Callard, M.D., John B. Flege, Jr., M.D., and Joseph C. Todd, M.D.

and Coronary Artery Surgery George M. Callard, M.D., John B. Flege, Jr., M.D., and Joseph C. Todd, M.D. Combined Valvular and Coronary Artery Surgery George M. Callard, M.D., John B. Flege, Jr., M.D., and Joseph C. Todd, M.D. ABSTRACT Between July, 97, and March, 975,45 patients underwent combined valvular

More information

ery: Comparison of Predicted and Observed Resu ts

ery: Comparison of Predicted and Observed Resu ts Preoperative Risk Assessment in Cardiac Sur K ery: Comparison of Predicted and Observed Resu ts Forrest L. Junod, M.D., Bradley J. Harlan, M.D., Janie Payne, R.N., Edward A. Smeloff, M.D., George E. Miller,

More information

Contrast Induced Nephropathy

Contrast Induced Nephropathy Contrast Induced Nephropathy O CIAKI refers to an abrupt deterioration in renal function associated with the administration of iodinated contrast media O CIAKI is characterized by an acute (within 48 hours)

More information

Technical Aspects and Initial Experience in Off-Pump Coronary Artery Bypass Grafting

Technical Aspects and Initial Experience in Off-Pump Coronary Artery Bypass Grafting J Med Sci 23;23(2):91-96 http://jms.ndmctsgh.edu.tw/23291.pdf Copyright 23 JMS Kuo-Chen Lee, et al. Technical Aspects and Initial Experience in Off-Pump Coronary Artery Bypass Grafting Kuo-Chen Lee, Guo-Jieng

More information

2017 Cardiology Survival Guide

2017 Cardiology Survival Guide 2017 Cardiology Survival Guide Chapter 4: Cardiac Catheterization/Percutaneous Coronary Intervention A cardiac catheterization involves a physician inserting a thin plastic tube (catheter) into an artery

More information

Link between effectiveness and cost data Costing was conducted prospectively on the same patient sample as that used in the effectiveness analysis.

Link between effectiveness and cost data Costing was conducted prospectively on the same patient sample as that used in the effectiveness analysis. Heparin after percutaneous intervention (HAPI): a prospective multicenter randomized trial of three heparin regimens after successful coronary intervention Rabah M, Mason D, Muller D W, Hundley R, Kugelmass

More information

Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease

Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease Gjin Ndrepepa, Tomohisa Tada, Massimiliano Fusaro, Lamin King, Martin Hadamitzky,

More information

1/3/2008. Karen Burke Priscilla LeMone Elaine Mohn-Brown. Medical-Surgical Nursing Care, 2e Karen Burke, Priscilla LeMone, and Elaine Mohn-Brown

1/3/2008. Karen Burke Priscilla LeMone Elaine Mohn-Brown. Medical-Surgical Nursing Care, 2e Karen Burke, Priscilla LeMone, and Elaine Mohn-Brown Medical-Surgical Nursing Care Second Edition Karen Burke Priscilla LeMone Elaine Mohn-Brown Chapter 26 Caring for Clients with Coronary Heart Disease and Dysrhythmias Coronary Heart Disease (CHD) Leading

More information

TCTAP Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI

TCTAP Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI Indian TUXEDO Trial In Medically Treated Diabetics Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI Executive Director and Dean Escorts Heart Institute & Medical Research Center and Fortis Hospitals, New Delhi

More information

VCU Pauley Heart Center: A 2009 US News Top 50 Heart and Heart Surgery Hospital

VCU Pauley Heart Center: A 2009 US News Top 50 Heart and Heart Surgery Hospital VCU Pauley Heart Center: A 2009 US News Top 50 Heart and Heart Surgery Hospital Complex PCI: Multivessel Disease George W. Vetrovec, MD. Kimmerling Chair of Cardiology VCU Pauley Heart Center Virginia

More information

AORTIC DISSECTIONS Current Management. TOMAS D. MARTIN, MD, LAT Professor, TCV Surgery Director UF Health Aortic Disease Center University of Florida

AORTIC DISSECTIONS Current Management. TOMAS D. MARTIN, MD, LAT Professor, TCV Surgery Director UF Health Aortic Disease Center University of Florida AORTIC DISSECTIONS Current Management TOMAS D. MARTIN, MD, LAT Professor, TCV Surgery Director UF Health Aortic Disease Center University of Florida DISCLOSURES Terumo Medtronic Cook Edwards Cryolife AORTIC

More information

Results of Reoperation

Results of Reoperation Results of Reoperation for Recurrent Angina Pectoris William I. Norwood, M.D., Lawrence H. Cohn, M.D., and John J. Collins, Jr., M.D. ABSTRACT Although a coronary bypass operation improves the quality

More information

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases Cardiovascular Disorders Lecture 3 Coronar Artery Diseases By Prof. El Sayed Abdel Fattah Eid Lecturer of Internal Medicine Delta University Coronary Heart Diseases It is the leading cause of death in

More information

Does Coronary Artery Bypass Graft Surgery Improve Survival Among Patients With End-Stage Renal Disease?

Does Coronary Artery Bypass Graft Surgery Improve Survival Among Patients With End-Stage Renal Disease? Does Coronary Artery Bypass Graft Surgery Improve Survival Among Patients With End-Stage Renal Disease? Todd M. Dewey, MD, Morley A. Herbert, PhD, Syma L. Prince, RN, Carrie L. Robbins, RN, Christina M.

More information

Coronary Artery Bypass Grafting Within 30 Days of an Acute Myocardial Infarction

Coronary Artery Bypass Grafting Within 30 Days of an Acute Myocardial Infarction Coronary Artery Bypass Grafting Within 30 Days of an Acute Myocardial Infarction Tej K. Kaul, FRCS, Barry L. Fields, MD, Shefton L. Riggins, MD, Guillermo C. Dacumos, MD, David A. Wyatt, MD, and Christopher

More information

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles

More information

DUKECATHR Dataset Dictionary

DUKECATHR Dataset Dictionary DUKECATHR Dataset Dictionary Version of DUKECATH dataset for educational use that has been modified to be unsuitable for clinical research or publication (Created Date and Time: 28OCT16 14:35) Table of

More information

Stent Trials in Acute Myocardial Infarction

Stent Trials in Acute Myocardial Infarction IAGS 1998 Proceedings Stent Trials in Acute Myocardial Infarction Alfredo Rodríguez MD, PhD Primary angioplasty in the early phase of acute myocardial infarction has been demonstrated to reduce in-hospital

More information

Competitive Blood Flow in the- Coronary Circulation Simulating Progression of Proximal Coronary Artery Disease After Saphenous Vein Bypass Surgery*

Competitive Blood Flow in the- Coronary Circulation Simulating Progression of Proximal Coronary Artery Disease After Saphenous Vein Bypass Surgery* Clin. Cardiol. 7, 179-183 (1984) @ Clinical Cardiology Publishing Co., Inc. Competitive Blood Flow in the- Coronary Circulation Simulating Progression of Proximal Coronary Artery Disease After Saphenous

More information

Improved long-term survival has been demonstrated by

Improved long-term survival has been demonstrated by Benefit of Bilateral Over Single Internal Mammary Artery Grafts for Multiple Coronary Artery Bypass Grafting Masahiro Endo, MD; Hiroshi Nishida, MD; Yasuko Tomizawa, MD; Hiroshi Kasanuki, MD Background

More information

Pulmonary Embolectomy:

Pulmonary Embolectomy: Pulmonary Embolectomy: Recommendation for early surgical intervention Tomas A. Salerno, M.D. Professor of Surgery, University of Miami Miller School of Medicine and Jackson Memorial Hospital Epidemiology

More information

OPCABG for Full Myocardial Revascularisation How we do it

OPCABG for Full Myocardial Revascularisation How we do it OPCABG for Full Myocardial Revascularisation How we do it 28 th SHA Conferance Dr.Farouk Oueida Head of Cardiac Surgery Dept. SBCC-Dammam KSA The Less Invasive CABG Full Revascularisation Full Sternotomy

More information